5-Fluoroindole Reduces the Bacterial Burden in a Murine Model of Mycobacterium tuberculosis Infection

Christiano E Neves; Josiane D Paz; Bruno L Abbadi; Raoní S Rambo; Alexia M Czeczot; Nathalia D M Sperotto; Adilio S Dadda; Rodrigo B M Silva; Marcia A Perelló; Guilherme A Gonçalves; Laura C González; Cristiano V Bizarro; Pablo Machado; Luiz A Basso

doi:10.1021/acsomega.4c03981

5-Fluoroindole Reduces the Bacterial Burden in a Murine Model of Mycobacterium tuberculosis Infection

ACS Omega. 2024 Jul 16;9(30):32969-32979. doi: 10.1021/acsomega.4c03981. eCollection 2024 Jul 30.

Authors

Christiano E Neves^{1

2}, Josiane D Paz^{1

2}, Bruno L Abbadi¹, Raoní S Rambo¹, Alexia M Czeczot^{1

2}, Nathalia D M Sperotto¹, Adilio S Dadda¹, Rodrigo B M Silva¹, Marcia A Perelló¹, Guilherme A Gonçalves^{1

3}, Laura C González^{1

2}, Cristiano V Bizarro^{1

2}, Pablo Machado^{1

2

3}, Luiz A Basso^{1

2

3}

Affiliations

¹ Instituto Nacional de Ciência e Tecnologia em Tuberculose, Centro de Pesquisas em Biologia Molecular e Funcional, Pontifícia Universidade Católica do Rio Grande do Sul, 90616-900 Porto Alegre, Rio Grande do Sul, Brazil.
² Programa de Pós-Graduação em Biologia Celular e Molecular, Pontifícia Universidade Católica do Rio Grande do Sul, 90616-900 Porto Alegre, Rio Grande do Sul, Brazil.
³ Programa de Pós-Graduação em Medicina e Ciências da Saúde, Pontifícia Universidade Católica do Rio Grande do Sul, 90616-900 Porto Alegre, Rio Grande do Sul, Brazil.

Abstract

Tuberculosis is a disease caused by a single pathogen that leads to a death toll estimated to be more than a million per year. Mycobacterium tuberculosis (Mtb), which affects mainly the lungs, spreads by airborne transmission when infectious respiratory particles from an infected human enter the respiratory tract of another person. Despite diagnosis and treatment being well established, the rise of cases of patients infected with Mtb strains with multidrug resistance to the antibiotics used in the regimen against the disease is alarming. Indole used as a core molecule has been described as a promising structure to treat several diseases. 5-Fluoroindole (5-FI) compound, evaluated in the free base and in the hydrochloride (5-FI.HCl) forms, inhibited the growth of pan-sensitive Mtb H37Rv strain in the same range (4.7-29.1 μM) of clinical isolates that have resistance to at least two first-line drugs. Although 5-FI showed no cytotoxicity in Vero and HepG2 cells, high permeability (2.4.10^-6 cm/s) in the PAMPA assay, and high metabolic stability (Cl_int 9.0 mL/min/kg) in rat liver microsomes, limited solubility at plasmatic and intestinal pH values prompted formation and employment of its salt form (5-FI.HCl). Although the 5-FI.HCl compound showed increased solubility at pH values of 7.4 and 9.1 and increased stability in aqueous solutions, data for intrinsic clearance (Cl_int = 48 mL/min/kg) and a half-life (t _1/2 = 12 min) showed decreased metabolic stability. As 5-FI.HCl showed both good absorption and ability to reach the systemic circulation of animals without the need to use vehicles containing cosolvents or surfactants, it was chosen to evaluate its effectiveness in the model of tuberculosis in mice. The in vivo results showed the concentration of the compound in plasma increasing within 30 min in the systemic circulation and the capacity of reducing the Mtb burden in the lungs at the concentration of 200 μmol/kg after 21 days of infection, with no toxicity in mice.